BioNTech Secures $90M from CEPI to Partner on Mpox Vaccine As It Enters Clinic

The German biotech is partnering with the Center for Epidemic Preparedness Innovations, accepting up to $90 million from the foundation as part of a broader pandemic preparation initiative.